NDATOPICALLOTION/SHAMPOO
Approved
May 1951
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SELSUN (selenium sulfide) by Sanofi. Approved for sunburn if used, decrease the risk of skin cancer, early skin aging caused by the sun. First approved in 1951.
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SELSUN (selenium sulfide) is a topical lotion/shampoo approved in 1951 for dermatological conditions including sunburn prevention, skin cancer risk reduction, and early skin aging caused by sun exposure. The mechanism of action and pharmacologic class are not fully specified in available data, but selenium sulfide acts as a topical therapeutic agent for UV-related skin damage.
LOE Approaching
With LOE approaching, the brand team is likely in defensive mode, prioritizing market retention and efficiency over expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on SELSUN at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.